Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Nasal drug products present significant opportunities to deliver drugs topically or systemically via innovative formulations or device designs. These products vary in device type and formulation (solution / suspension) however can be an ideal platform for the delivery of both small and large molecules. Teresa Iley, Intertek’s Director of Pharmaceutical Development & Manufacturing, will present an introduction to nasal drug products including the benefits of this platform, regulatory considerations and approaches to over the challenges of development for this product type.
June 12, 2019 | 16:00 CEST, 15:00 BST, 10:00 EDT
Register now by completing the form below
Scheduling conflict? Register anyway to access the post-event recording